Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|December 13, 2021
Long term survival in multiple myeloma: a single institution experience in underprivileged circumstancesLorena Bojalil-Alvarez, Morie A Gertz, Elizabeth Garcia-Villaseñor, et al.
The American Journal of Surgical Pathology|October 7, 2017
Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital TractJelena Mirkovic, Marie McFarland, Elizabeth Garcia, et al.
Cancer Research|January 11, 2007
Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastomaMary K Danks, K Jin Yoon, Rebecca A Bush, et al.
Journal of Pediatric Surgery|January 9, 2007
Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastomaPaxton V Dickson, John B Hamner, Rebecca A Burger, et al.
JAMA Dermatology|September 5, 2014
Novel genetic mutations in a sporadic port-wine stainChristine Guo Lian, Lynette M Sholl, Labib R Zakka, et al.
Neuroimage|June 15, 2007
Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial gliomaDavid Lin, Joseph Najbauer, Paul M Salvaterra, et al.
Plos One|April 28, 2012
Cellular host responses to gliomasJoseph Najbauer, Peter C Huszthy, Michael E Barish, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 12, 2016
Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CAJaclyn C Watkins, Brooke E Howitt, Neil S Horowitz, et al.
Journal of Neuroimmunology|July 30, 2020
Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: A two-year prospective studyRaquel Espinosa-Cárdenas, Asiel Arce-Sillas, Diana Álvarez-Luquin, et al.
Current Allergy and Asthma Reports|May 11, 2018
Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to ClinicDésirée E S Larenas-Linnemann, Claudio A S Parisi, Carla Ritchie, et al.
Pageof 11